1. Empathy and the Educational Approach to Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants
- Author
-
Doris Barcellona, Antonella Mameli, Francesco Marongiu, and Silvia Marongiu
- Subjects
medicine.medical_specialty ,Vitamin K ,Laboratory monitoring ,media_common.quotation_subject ,Administration, Oral ,Empathy ,Interpersonal communication ,Poor adherence ,Educational approach ,Atrial Fibrillation ,medicine ,Humans ,Pharmacology (medical) ,Intensive care medicine ,education ,media_common ,Pharmacology ,Narrative medicine ,education.field_of_study ,business.industry ,Anticoagulants ,Atrial fibrillation ,General Medicine ,medicine.disease ,Disconnection ,business - Abstract
Direct Oral Anticoagulants (DOACs) have shown to be at least effective and safer than anti-vitamin K (VKA) for the prophylaxis of cardioembolism during AF. These drugs do not need laboratory monitoring such as the VKA anticoagulants, but they are at risk of poor adherence and persistence as all drugs taken by mouth. Against this drawback, empathy may have an important role because it is important as a tool to be used for effective interpersonal communication. Patients like to be heard and understand that those who listen to them are immersed in their world. Empathy is part, and is a founding principle, of Narrative Medicine which today is a real discipline with many advantages because it is intrinsically therapeutic for the patient (in telling and being heard). Empathy prevents the disconnection that can intervene between the doctor and the patients. Have we ever wondered if we are sufficiently empathetic? Is it possible to measure our empathy? Yes, across Jefferson's scale. A high score on Jefferson's scale could certainly further improve the quality of the management of anticoagulated patients.
- Published
- 2021